Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02063958
Title Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Esanex Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale Arizona 85259-5499 United States Details
Stanford Medicine Stanford California 94305 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Center for Cancer Research, National Cancer Institute Bethesda Maryland 20892 United States Details
hackensack University Medical Center Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field